Kazam Joshua A
SEC insider (Form 3/4/5 filer). CIK 0001221355. Director at Allogene Therapeutics, Inc. (ALLO) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Kazam Joshua A has filed insider reports for
- Allogene Therapeutics, Inc. (ALLO): Director
- Kronos Bio, Inc. (KRON): Director
Kazam Joshua A
CIK: 0001221355
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 18, 2026ALLO
Allogene Therapeutics, Inc.
ExerciseDirect47.7K shares- - Jun 18, 2026ALLO
Allogene Therapeutics, Inc.
AwardDirectRestricted Stock Unit
95.4K shares- - Dec 18, 2025ALLO
Allogene Therapeutics, Inc.
ExerciseDirect47.7K shares- - Jun 20, 2025KRON
Kronos Bio, Inc.
DispositionDirectStock Option (Right to Buy)
20.6K shares- - Jun 20, 2025KRON
Kronos Bio, Inc.
DispositionDirectStock Option (Right to Buy)
34K shares- - Jun 20, 2025KRON
Kronos Bio, Inc.
DispositionDirectStock Option (Right to Buy)
34K shares- - Jun 20, 2025KRON
Kronos Bio, Inc.
DispositionDirectStock Option (Right to Buy)
34K shares- - Jun 20, 2025KRON
Kronos Bio, Inc.
Tender OfferDirect94.5K shares at avg. $0.57$54K - Jun 18, 2025ALLO
Allogene Therapeutics, Inc.
AwardDirectRestricted Stock Unit
94.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  ALLO Allogene Therapeutics, Inc. | Exercise | 47,700 | - | $0 | Direct |
| Jun 18, 2026 | ALLO Allogene Therapeutics, Inc. | Award Restricted Stock Unit | 95,400 | - | - | Direct |
| Dec 18, 2025 | ALLO Allogene Therapeutics, Inc. | Exercise | 47,700 | - | - | Direct |
| Jun 20, 2025 |  KRON Kronos Bio, Inc. | Disposition Stock Option (Right to Buy) | 20,600 | - | - | Direct |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | Disposition Stock Option (Right to Buy) | 34,000 | - | - | Direct |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | Disposition Stock Option (Right to Buy) | 34,000 | - | - | Direct |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | Disposition Stock Option (Right to Buy) | 34,000 | - | - | Direct |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | Tender Offer | 94,481 | $0.57 | $53,854 | Direct |
| Jun 18, 2025 | ALLO Allogene Therapeutics, Inc. | Award Restricted Stock Unit | 94,500 | - | - | Direct |
1-9 of 9 transactions